Sfoglia per Autore
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature
2007-01-01 Carmelo, Carlo-Stella; Cristiana, Lavazza; Giacomini, A; Daniela, Sia; Loredana, Cleris; Massimo Di, Nicola; Paolo, Longoni; Marco, Milanesi; Michele, Magni; Marco, Righi; Maura, Francolini; Annunziata, Gloghini; Anna, Guidetti; Antonino, Carbone; and Alessandro M., Gianni
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas
2008-01-01 Carmelo, Carlo-Stella; Cristiana, Lavazza; Giacomini, A; Loredana, Cleris; Daniela, Sia; Paolo, Longoni; Marco, Milanesi; Michele, Magni; Massimo Di, Nicola; Annunziata, Gloghini; Antonino, Carbone; Marco, Righi; Franca, Formelli; and Alessandro M., Gianni
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft
2009-01-01 Guidetti, A.; Carlo Stella, C.; Ruella, M.; Devizzi, L.; Sia, D.; Giacomini, A; Locatelli, S. L.; Testi, A.; Magni, M.; Di Nicola, M.; Matteucci, P.; Buttiglieri, S.; Risso, A.; Tarella, C.; Gianni, A. M.
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression
2009-01-01 Di Nicola, M.; Zappasodi, R.; Baldan, F.; Iorio, M. V.; Magni, M.; Tagliabue, E.; Giacomini, A; Croce, C. M.; Carlo- Stella, C.; Gianni, A. M.
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
2009-01-01 Righi, Marco; Giacomini, Arianna; Lavazza, Cristiana; Sia, Daniela; Carlo-Stella, Carmelo; Gianni, Alessandro M.
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients
2010-01-01 Anna, Guidetti; Carmelo, Carlo-Stella; Marco, Ruella; Rosalba, Miceli; Liliana, Devizzi; Daniela, Sia; Silvia, Locatelli; Giacomini, A; Michele, Magni; Paola, Matteucci; Stefano, Buttiglieri; Alessandra, Risso; Luigi, Mariani; Roberto, Passera; Massimo Di, Nicola; Corrado, Tarella; and Alessandro M., Gianni
Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature
2010-01-01 Lavazza, Cristiana; Carlo-Stella, Carmelo; Giacomini, Arianna; Cleris, Loredana; Righi, Marco; Sia, Daniela; Di Nicola, Massimo; Magni, Michele; Longoni, Paolo; Milanesi, Marco; Francolini, Maura; Gloghini, Annunziata; Carbone, Antonino; Formelli, Franca; Gianni, Alessandro M.
Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma
2011-01-01 Silvia, Locatelli; Giacomini, A; Anna, Guidetti; Loredana, Cleris; Michele, Magni; Massimo Di, Nicola; Roberta, Mortarini; Alessandro, M Gianni; Andrea, Anichini; and Carmelo, Carlo-Stella
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells
2011-01-01 Carlo-Stella, C.; Gianni, A. M.; Giacomini, A.; Lavazza, C.; Locatelli, S. L.
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
2011-01-01 Guidetti, Anna; Carlo Stella, Carmelo; Ruella, Marco; Miceli, Rosalba; Devizzi, Lilli; Locatelli, Silvia L; Giacomini, Arianna; Testi, Adele; Buttiglieri, Stefano; Risso, Alessandra; Mariani, Luigi; Di Nicola, Massimo; Passera, Roberto; Tarella, Corrado; Gianni, Alessandro M.
Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias
2012-01-01 Guidetti, Anna; Giacomini, A; Silvia L., Locatelli; Carmelo, Carlo-Stella
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model
2012-01-01 Rossini, Anna; Giussani, Marta; Giacomini, Arianna; Guarnotta, Carla; Tagliabue, Elda; Balsari, Andrea
Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth
2012-01-01 Giacomini, Arianna; Lavazza, Cristiana; Grazia, Giulia; Locatelli, Silvia Laura; Cleris, Loredana; Righi, Marco; Gianni, Alessandro Massimo; Carlo Stella, Carmelo
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells
2013-01-01 Carlo Stella, Carmelo; Locatelli, Silvia L; Giacomini, Arianna; Cleris, Loredana; Saba, Elena; Righi, Marco; Guidetti, Anna; Gianni, Alessandro M.
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy
2013-01-01 Belleri, Mirella; Ronca, Roberto; Coltrini, Daniela; Nico, B.; Ribatti, D.; Poliani, Pietro Luigi; Giacomini, Arianna; Alessi, Patrizia; Marchesini, S.; Santos, M. B.; Bongarzone, E. R.; Presta, Marco
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies
2013-01-01 Righi, Marco; Giacomini, Arianna; Cleris, Loredana; Carlo Stella, Carmelo
Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL)
2013-01-01 Buttiglieri, Stefano; Carlo Stella, Carmelo; Spatola, Tiziana; Pulito, Roberta; Naldini, Luigi; Anichini, Andrea; Magni, Michele; Giacomini, Arianna; Tarella, Corrado; Gianni, Alessandro M.
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
2013-01-01 Locatelli, S. L; Giacomini, Arianna; Guidetti, A; Cleris, L; Mortarini, R; Anichini, A; Gianni, A. M; Carlo Stella, C.
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer.
2013-01-01 Ronca, Roberto; Alessi, Patrizia; Coltrini, Daniela; DI SALLE, Emanuela; Giacomini, Arianna; Leali, Daria; Corsini, Michela; Belleri, Mirella; Tobia, Chiara; Garlanda, C.; Bonomi, Elisa; Tardanico, R.; Vermi, William; Presta, Marco
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells.
2013-01-01 Giacomini, Arianna; Righi, M; Cleris, L; Locatelli, Sl; Mitola, Stefania Maria Filomena; Daidone, Mg; Gianni, Am; Carlo Stella, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature | 1-gen-2007 | Carmelo, Carlo-Stella; Cristiana, Lavazza; Giacomini, A; Daniela, Sia; Loredana, Cleris; Massimo Di, Nicola; Paolo, Longoni; Marco, Milanesi; Michele, Magni; Marco, Righi; Maura, Francolini; Annunziata, Gloghini; Anna, Guidetti; Antonino, Carbone; and Alessandro M., Gianni | |
| Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas | 1-gen-2008 | Carmelo, Carlo-Stella; Cristiana, Lavazza; Giacomini, A; Loredana, Cleris; Daniela, Sia; Paolo, Longoni; Marco, Milanesi; Michele, Magni; Massimo Di, Nicola; Annunziata, Gloghini; Antonino, Carbone; Marco, Righi; Franca, Formelli; and Alessandro M., Gianni | |
| Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft | 1-gen-2009 | Guidetti, A.; Carlo Stella, C.; Ruella, M.; Devizzi, L.; Sia, D.; Giacomini, A; Locatelli, S. L.; Testi, A.; Magni, M.; Di Nicola, M.; Matteucci, P.; Buttiglieri, S.; Risso, A.; Tarella, C.; Gianni, A. M. | |
| The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression | 1-gen-2009 | Di Nicola, M.; Zappasodi, R.; Baldan, F.; Iorio, M. V.; Magni, M.; Tagliabue, E.; Giacomini, A; Croce, C. M.; Carlo- Stella, C.; Gianni, A. M. | |
| A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments | 1-gen-2009 | Righi, Marco; Giacomini, Arianna; Lavazza, Cristiana; Sia, Daniela; Carlo-Stella, Carmelo; Gianni, Alessandro M. | |
| The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients | 1-gen-2010 | Anna, Guidetti; Carmelo, Carlo-Stella; Marco, Ruella; Rosalba, Miceli; Liliana, Devizzi; Daniela, Sia; Silvia, Locatelli; Giacomini, A; Michele, Magni; Paola, Matteucci; Stefano, Buttiglieri; Alessandra, Risso; Luigi, Mariani; Roberto, Passera; Massimo Di, Nicola; Corrado, Tarella; and Alessandro M., Gianni | |
| Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature | 1-gen-2010 | Lavazza, Cristiana; Carlo-Stella, Carmelo; Giacomini, Arianna; Cleris, Loredana; Righi, Marco; Sia, Daniela; Di Nicola, Massimo; Magni, Michele; Longoni, Paolo; Milanesi, Marco; Francolini, Maura; Gloghini, Annunziata; Carbone, Antonino; Formelli, Franca; Gianni, Alessandro M. | |
| Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma | 1-gen-2011 | Silvia, Locatelli; Giacomini, A; Anna, Guidetti; Loredana, Cleris; Michele, Magni; Massimo Di, Nicola; Roberta, Mortarini; Alessandro, M Gianni; Andrea, Anichini; and Carmelo, Carlo-Stella | |
| Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells | 1-gen-2011 | Carlo-Stella, C.; Gianni, A. M.; Giacomini, A.; Lavazza, C.; Locatelli, S. L. | |
| Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia | 1-gen-2011 | Guidetti, Anna; Carlo Stella, Carmelo; Ruella, Marco; Miceli, Rosalba; Devizzi, Lilli; Locatelli, Silvia L; Giacomini, Arianna; Testi, Adele; Buttiglieri, Stefano; Risso, Alessandra; Mariani, Luigi; Di Nicola, Massimo; Passera, Roberto; Tarella, Corrado; Gianni, Alessandro M. | |
| Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias | 1-gen-2012 | Guidetti, Anna; Giacomini, A; Silvia L., Locatelli; Carmelo, Carlo-Stella | |
| Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model | 1-gen-2012 | Rossini, Anna; Giussani, Marta; Giacomini, Arianna; Guarnotta, Carla; Tagliabue, Elda; Balsari, Andrea | |
| Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth | 1-gen-2012 | Giacomini, Arianna; Lavazza, Cristiana; Grazia, Giulia; Locatelli, Silvia Laura; Cleris, Loredana; Righi, Marco; Gianni, Alessandro Massimo; Carlo Stella, Carmelo | |
| Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells | 1-gen-2013 | Carlo Stella, Carmelo; Locatelli, Silvia L; Giacomini, Arianna; Cleris, Loredana; Saba, Elena; Righi, Marco; Guidetti, Anna; Gianni, Alessandro M. | |
| Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy | 1-gen-2013 | Belleri, Mirella; Ronca, Roberto; Coltrini, Daniela; Nico, B.; Ribatti, D.; Poliani, Pietro Luigi; Giacomini, Arianna; Alessi, Patrizia; Marchesini, S.; Santos, M. B.; Bongarzone, E. R.; Presta, Marco | |
| (3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies | 1-gen-2013 | Righi, Marco; Giacomini, Arianna; Cleris, Loredana; Carlo Stella, Carmelo | |
| Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL) | 1-gen-2013 | Buttiglieri, Stefano; Carlo Stella, Carmelo; Spatola, Tiziana; Pulito, Roberta; Naldini, Luigi; Anichini, Andrea; Magni, Michele; Giacomini, Arianna; Tarella, Corrado; Gianni, Alessandro M. | |
| Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts | 1-gen-2013 | Locatelli, S. L; Giacomini, Arianna; Guidetti, A; Cleris, L; Mortarini, R; Anichini, A; Gianni, A. M; Carlo Stella, C. | |
| Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. | 1-gen-2013 | Ronca, Roberto; Alessi, Patrizia; Coltrini, Daniela; DI SALLE, Emanuela; Giacomini, Arianna; Leali, Daria; Corsini, Michela; Belleri, Mirella; Tobia, Chiara; Garlanda, C.; Bonomi, Elisa; Tardanico, R.; Vermi, William; Presta, Marco | |
| Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. | 1-gen-2013 | Giacomini, Arianna; Righi, M; Cleris, L; Locatelli, Sl; Mitola, Stefania Maria Filomena; Daidone, Mg; Gianni, Am; Carlo Stella, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile